You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment

  • Technology appraisal guidance
  • Reference number: TA333
  • Published:  25 February 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document

Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document Renal cell carcinoma (advanced) - axitinib: response to consultee, commentator and public comments on the Appraisal Consultation Document
28 March 2013
(253.45 Kb 13 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 25 March 2013

Back to top